AntineoplasticsAntineoplastics
What is Cancer ? Cancer is a disorder of cell division (leading cause of death).
Cancers most commonly occur in: breast (♀) - prostate (♂) - lung - colon - rectum
Common characteristics of neoplastic cells: - Persistent proliferation and Immortality -Dedifferentiation. - Invasive growth - Formation of metastases -Sustained angiogenesis.
AntineoplasticsAntineoplastics
Cancer Etiology -The abnormal behavior of cancer cells results from DNA alterations.
Malignant transformation results from a combination of activation of oncogenes and inactivation of tumor suppressor genes.
- These genetic alterations are caused by: Chemical carcinogens (cigarette smoking). Pathogens (hepatitis C virus, H. pylori). Radiation (X-rays). Hereditary factors. Drugs (estrogen).
AntineoplasticsAntineoplastics
Treatment Modalities: 1.Surgery (solid tumors). 2. Radiation (solid tumors). 3. Drug therapy: -Disseminated cancers (leukemias, lymphomas & widespread metastases. -Some localized tumors e.g. testicular carcinoma. -Adjuvant to surgery & radiation.
AntineoplasticsAntineoplastics
Goals of therapy: - Cure e.g. Hodgkin6 s disease - Prophylaxis of recurrence - Prolong survival - Palliation of symptoms
Outcome of therapy depends on: -General health of patient -Responsiveness of cancer type (size, location, grade, etc.). -Drug resistance.
AntineoplasticsAntineoplastics
Drug Selection
Combination therapy is more effective than single drug therapy - maximal cell kill - ↓ Injury to normal cells. - slow/prevent development of drug resistant
Criteria of drug selection for combination therapy - different MOAs (act at diff. cell-cycle stages) - different toxicities (↓overlapping toxicities) - Each drug effective by itself
AntineoplasticsAntineoplastics
Tumor stagingTumor stagingMost commonly applied staging system for solid tumors is TNM (tumor-nodes-metastases) classification where a numerical value is assigned to each letter to indicate size or disease extent.TNM system
T: refers to the size of the primary tumor (0-4) e.g. T4 (large size tumor).
N: refers to the extent of lymph nodes involvement (0-4)e.g. N0 (no lymph node disease).
Nx(Lymph nodes not assessed).M: refers to the presence or absence of distant metastasis (0-1)
e.g. M1 (distant metastasis).
M0 ( No distant metastasis). Mx (distant metastasis not assessed).
T2N1M0 (moderate size tumor with limited nodal disease and no distant metastases).
AntineoplasticsAntineoplastics
Growth Fraction = GF = Proliferating cells (S or M phase) /resting cells (G0).
Cell-cycle phase specific (phase specific) drugsCell-cycle phase non-specific (cycle specific) drugs
G1 = 40%S = 39%G2 = 19%M = 2%
Checkpoints:P27: G1-SP53: G2-M
AntineoplasticsAntineoplastics
Cell-Cycle Drug Effects
1. Cell-cycle phase-specific drugs:
Must be present for an extended time → given by infusions or in frequent small doses.
G1-phase specific: Asparaginase (Enzyme).
S-phase specific: Methotrexate, Fluorouracil, Mercaptopurine (Antimetabolites).
G2-phase specific: Bleomycin (Antitumor antibiotic)
M-phase specific: Vinca alkaloids (Vincristine, Vinblastine) (Mitotic inhibitors).
AntineoplasticsAntineoplastics
2. Cell-cycle phase non-specific drugs (cycle-specific):
Act during any phase including G0. More toxic to proliferating cells than G0 cells.
cyclophosphamide. Carmustine: Alkylating agents.
Cisplatin, Carboplatin: Platinium compds.
Doxorubicin: Antitumor antibiotics.
AntineoplasticsAntineoplastics
Toxicity to malignant tissues & normal tissues with↑ growth fraction
(bone marrow – GIT epithelium – hair follicles – sperm-forming cells) Myelosuppression “most common”
Neutropenia, Thrombocytopenia, Anemia.
GIT Toxicities Nausea & Vomiting GI mucosal irritation (stomatitis, diarrhea) Dermatologic Disorders: Alopecia, Extravasation, Photosensitivity.
Infertility Tumor Lysis Syndrome (TLS):
Massive cell death & DNA degradation → hyperuricemia → renal injury
AntineoplasticsAntineoplastics
Unique toxicities
A.Cardiotoxicity: Doxorubicin
B. Nephrotoxicity: Cisplatin & & Methotrexate..
C. Pulmonary Toxicity: Bleomycin. D. Hepatotoxicity: Asparaginase
E. Hemorrhagic cystitis: Cyclophosphamide → acrolein F. Neurotoxicity: Vincristine, Cisplatin.
AntineoplasticsAntineoplastics
ERA & PRAERA & PRA
Estrogen Receptor Assay Progesterone Receptor Assay
Lab test done to find out if cancer cells have estrogen (progesterone) receptors
Cells with ERs need E to grow while cells with PRs need P to grow.
ER+ growth of cancer cells is E-dependant ER¯ growth of cancer cells is E-independent
AntineoplasticsAntineoplastics
Tumor markersTumor markers
Tumor markers are substances found in blood, urine and tissues, produced by tumor cells or by other body cells in response to cancer or certain benign conditions.
An elevated level of a tumor marker can indicate cancer; however, there can also be other causes of the elevation.
Tumor marker levels are checked at the time of diagnosis; before, during, and after therapy; and then periodically to monitor for recurrence.
AntineoplasticsAntineoplastics
Tumor Marker Associated Tumor
CEACEA Carcinoembryonic Carcinoembryonic AntigenAntigen
GIT, BREAST, LUNG GIT, BREAST, LUNG CANCERSCANCERS
CA-125CA-125 Cancer Antigen-125 Cancer Antigen-125 OVARIAN CANCEROVARIAN CANCER
PSA PSA Prostate Specific Prostate Specific AntigenAntigen
PROSTATE CANCERPROSTATE CANCER
β-HCGβ-HCG Human Chorionic Human Chorionic GonadropinGonadropin
TESTICULAR CANCERTESTICULAR CANCER
AFPAFP Alpha-fetoproteinAlpha-fetoprotein LIVER CANCERLIVER CANCER
Tg Tg ThyroglobulinThyroglobulin THYROID CANCERTHYROID CANCER
AntineoplasticsAntineoplastics
If a man has ↑ PSA level Search for PC
If a person has ↑ β-HCG level
Search for testicular cancer
If a person has ↑ AFP level Search for liver
cancer
AntineoplasticsAntineoplastics
M0 means… No distant metastasis
Nx means…
Lymph nodes not assessed
Mx means…. Distant metastasis not assessed
Top Related